Mortality from ischaemic heart disease: sex-specific effects of transferrin saturation, serum iron, and total iron binding capacity. The HUNT study

被引:17
作者
Morkedal, Bjorn [1 ]
Laugsand, Lars E. [1 ]
Romundstad, Pal R. [1 ]
Vatten, Lars J. [1 ]
机构
[1] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Trondheim, Norway
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2011年 / 18卷 / 05期
关键词
Ischaemic heart disease; serum iron; sex; total iron binding capacity; transferrin saturation; RISK-FACTOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; MEDICAL PROGRESS; ANEMIA; STORES; HEMOCHROMATOSIS; ATHEROSCLEROSIS; HEMOGLOBIN; OUTCOMES;
D O I
10.1177/1741826710390134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We assessed sex-specific associations of iron status with ischaemic heart disease (IHD) mortality and explored whether the strength of the associations changed during follow-up. Design: Prospective cohort study. Methods: During 11.4 years of follow-up, IHD mortality was studied in 28,154 men and 32,644 women without known myocardial infarction or stroke at baseline. Results: During follow-up, 1,034 men and women died from IHD. Compared to being in the highest quartile of transferrin saturation, the multivariate adjusted hazard ratio associated with being in the lowest quartile was 1.3 (95% CI 1.0-1.6) in men and 1.4 (95% CI 1.0-1.9) in women. The corresponding hazard ratios for serum iron were 1.5 (95% CI 1.1-1.9) in men and 1.1 (95% CI 0.8-1.4) in women, and for total iron binding capacity (TIBC), the hazard ratio of being in the highest compared to the lowest quartile was 0.9 (95% CI 0.8-1.2) in men and 1.5 (95% CI 1.1-2.0) in women. Associations with iron status were stronger in the early than in later stages of follow-up. Conclusions: The results suggest that low iron status may be a late sign of IHD pathology or that unknown prevalent disease at baseline could influence the associations.
引用
收藏
页码:687 / 694
页数:8
相关论文
共 33 条
[1]   Anemia and its relationship to clinical outcome in heart failure [J].
Anand, I ;
McMurray, JJV ;
Whitmore, J ;
Warren, M ;
Pham, A ;
McCamish, MA ;
Burton, PBJ .
CIRCULATION, 2004, 110 (02) :149-154
[2]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[3]  
Åsberg A, 2001, SCAND J GASTROENTERO, V36, P1108
[4]  
ASPEREN IA, 1995, INT J EPIDEMIOL, V24, P665
[5]   IRON STORES ARE NOT ASSOCIATED WITH ACUTE MYOCARDIAL-INFARCTION [J].
BAER, DM ;
TEKAWA, IS ;
HURLEY, LB .
CIRCULATION, 1994, 89 (06) :2915-2918
[6]   Serum iron level, coronary artery disease, and all-cause mortality in older men and women [J].
Corti, MC ;
Guralnik, JM ;
Salive, ME ;
Ferrucci, L ;
Pahor, M ;
Wallace, RB ;
Hennekens, CH .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (02) :120-127
[7]   Coronary heart disease and iron status - Meta-analyses of prospective studies [J].
Danesh, J ;
Appleby, P .
CIRCULATION, 1999, 99 (07) :852-854
[8]   High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency [J].
Das Gupta, A ;
Abbi, A .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (03) :158-161
[9]   Comparison of two smoothing methods for exploring waning vaccine effects [J].
Durham, LK ;
Halloran, ME ;
Longini, IM ;
Manatunga, AK .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 1999, 48 :395-407
[10]   Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study [J].
Fox, CJ ;
Cullen, DJ ;
Knuiman, MW ;
Cumpston, GN ;
Divitini, ML ;
Rossi, E ;
Gochee, PA ;
Powell, LW ;
Olynyk, JK .
JOURNAL OF CARDIOVASCULAR RISK, 2002, 9 (05) :287-293